Emerging Use of Nanotechnology for the Treatment of Liver Diseases
- Authors: Melchiorre Cervello1, Lydia Giannitrapani2, Maria Rita Emma3, Giuseppa Augello4, Antonella Cusimano5, Daniele Balasus6, Antonina Azzolina7, Maurizio Soresi8, Giuseppe Montalto9
-
View Affiliations Hide Affiliations1 Institute of Biomedicine and Molecular Immunology “Alberto Monroy”, National Research Council (CNR), Via Ugo La Malfa 153, 90146 Palermo, Italy 2 Biomedical Department of Internal Medicine and Specialties, University of Palermo, Via del Vespro 143, 90127 Palermo, Italy. 3 Institute of Biomedicine and Molecular Immunology “Alberto Monroy”, National Research Council (CNR), Via Ugo La Malfa 153, 90146 Palermo, Italy 4 Institute of Biomedicine and Molecular Immunology “Alberto Monroy”, National Research Council (CNR), Via Ugo La Malfa 153, 90146 Palermo, Italy 5 Institute of Biomedicine and Molecular Immunology “Alberto Monroy”, National Research Council (CNR), Via Ugo La Malfa 153, 90146 Palermo, Italy 6 Institute of Biomedicine and Molecular Immunology “Alberto Monroy”, National Research Council (CNR), Via Ugo La Malfa 153, 90146 Palermo, Italy 7 Institute of Biomedicine and Molecular Immunology “Alberto Monroy”, National Research Council (CNR), Via Ugo La Malfa 153, 90146 Palermo, Italy 8 Biomedical Department of Internal Medicine and Specialties, University of Palermo, Via del Vespro 143, 90127 Palermo, Italy. 9 Institute of Biomedicine and Molecular Immunology "Alberto Monroy", National Research Council (CNR), Via Ugo La Malfa 153, 90146 Palermo, Italy.
- Source: Frontiers in Nanomedicine , pp 47-83
- Publication Date: April 2015
- Language: English
Preview this chapter:
Emerging Use of Nanotechnology for the Treatment of Liver Diseases, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9781681080468/chap-2-1.gif
Liver diseases, including viral hepatitis, resulting from hepatitis B or C virus infection, liver cirrhosis and hepatocellular carcinoma pose great global health challenges due to the limited curative treatment options. The application of nanoparticles has emerged as a rapidly evolving area for safely delivering therapeutic agents (i.e. drugs and nucleic acid) to treat a range of diseases, including those of the liver. In this chapter, we give an overview of various nanotechnology approaches which can be employed when treating liver diseases, focusing in particular on liver infections, fibrosis and cancer.
Hardbound ISBN:
9781681080475
Ebook ISBN:
9781681080468
Book DOI:
https://doi.org/10.2174/240591371150101
-
From This Site
/content/books/9781681080468.chap-2dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
/content/books/9781681080468.chap-2
dcterms_subject,pub_keyword
-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData
10
5
Chapter
content/books/9781681080468
Book
false
en